>peptide 1 (30 aa)
SFMVFLIHYLQRLHAYSGLKDPKLNNEVGK*
>peptide 2 (53 aa)
ALSWYFSSIIFNACMLTQVLKIPNSTMKSANRHFRVEKQSTKGRERERERKEY*
>CNT0003275
GCTCTTTCATGGTATTTCTCATCCATTATCTTCAACGCTTGCATGCTTACTCAGGTCTTAAAGATCCCAAACTCAACAATGAAGTCGGCAAATAGGCATT
TCAGGGTGGAAAAACAAAGCACCAAGGGGAGAGAGAGAGAGAGAGAGAGAAAGGAGTATTAGAATGAGATGGTTAAAAGGATAATAGTTTACAGGACACC
TATGTTCTTAAGTCCAAGAACAACCCCAACCCCAATTATGTGACCTACAGTTCCACATGCCAAGGTATCTGCAAGGGTGAAGCCAGCTGGGTCTCCAGTC
TGCAGCCCTGAGTCCCTTACCTCAAGCTTCAATCCCGCAGTCGCCTTCCTGTTGGCCGATGGAGCCAACCCAAATCGCCCAGCAAACAGCATTAGGCTTG
TTGAAGTCACCATAATCT
| Potential function | Interacting transcript | Gene description | Transcript biotype | lncRNA id | Alignment score (LAST) | Alignment length | Transcript region involved in interaction | Genomic orientation of interacting RNAs |
|---|---|---|---|---|---|---|---|---|
| VIT_10s0003g04350.t01 | Putative uncharacterized protein | protein coding | CNT0003275 | 1224 | 418 | CDS_UTR | Cis |